Final-Program-ATS-2023-AP.vp

MONDAY • MAY 22

147

P716 Early Outcomes and Comparisons of Biologic Therapy for Severe Asthma in a Pediatric Cohort/ N. Koka, Little Rock, AR P717 Reduced Peripheral CD5 + Regulatory B Cells Are Associated With Sputum Autoantibodies in Eosinophilic Asthma/ N.S. Tan, Hamilton, Canada P718 Diet Regulation of Immunometabolism in Asthma/ S.A.A. Comhair, Cleveland, OH P719 Different Airway Mucus Plug Phenotypes in Fatal and Non-Fatal Asthma/ M. Liegeois, San Francisco, CA P720 Mitochondrial Hydrogen Peroxide Is Required for Preventing Allergic Airway Disease in Early Life/ H. Yuan, Pittsburgh, PA P721 Risk of COVID-19 Incidence and Severity Among Patients With Severe Asthma Receiving Therapy With Monoclonal Antibodies/ R. Dhand, Knoxville, TN P722 Genetic Risk Profiling for Indoor and Outdoor Aeroallergens Sensitization in a French-Canadian Family Asthma Cohort/ M.-P. Bouchard, Saguenay, Canada P723 Paradoxical Bronchodilator Response Is Associated With Increased Risk of Asthma Exacerbations/ B.F. Fakhry, Cleveland, OH P724 Efficacy of As-needed Use of Albuterol-Budesonide in Patients With Moderate-to-Severe Asthma Who Are Adherent to Maintenance Therapy/ A. Papi, Ferrara, Italy

P702 The Validity of the Asthma Daytime Symptoms Diary (ADSD) and the Asthma Nighttime Symptoms Diary (ANSD) As Measures of Symptoms in Patients With Moderate-to-Severe Asthma/ T. Keeley, Brentford, Middlesex, United Kingdom P703 The Use of Depot Formulation Systemic Steroid Ionjections in Young Adults With Asthma - a Nationwide Study/ K.E.J. Håkansson, Hvidovre, Denmark P704 MiRNAs and Baseline Asthma Daytime Symptoms in Two Pediatric Cohorts/ B. Desai, La Jolla, CA P705 Enhanced Blocking toward TSLP Variants at Lung Barrier Protects against Experimental Asthma/ C. Guo, Hangzhou, China P706 Plant Protease Inhibitors in Mice ACO Model: Comparison With Corticosteroid/ J. Joao, Sao Paulo, Brazil P707 Comparison of Extrafine Beclomethasone Dipropionate/formoterol Fumarate (BDP/FF) Dry Powder Inhaler (DPI) and Pressurized Metered-dose Inhaler pMDI in Chinese Patients With Asthma: The FORTUNE Study/ J. Zheng, Guangzhou, China P708 Assessment of Rescue Medication Use According to the Asthma Control Questionnaire 6-items (ACQ-6) Vs Daily E-diaries: A Pooled Analysis of the Trimaran and Trigger Studies/ D. Singh, Manchester, United Kingdom P709 Anti-alarmins for Severe Asthma: A Systematic Review and Meta-analysis/ T. Ho, Hamilton, Canada P710 a and ß Tryptase Is Released From Mast Cells by IgE Cross-linking and Increased a/ß Ratio Is Associated With Diminished PAR-2 Activity/ N. Rathore, South San Francisco, CA P711 Cross-Sectional Associations Between the Chronic Airways Assessment Test and Clinical Characteristics in Asthma and/or COPD in the NOVELTY Study/ P.W. Jones, Brentford, United Kingdom P712 Associations Between the Chronic Airways Assessment Test and History of Physician-Reported Exacerbations in Asthma and/or COPD in the NOVELTY Study/ P.W. Jones, Brentford, United Kingdom P713 Characterization of OCS Use Among Patients With Physician-Assigned Asthma and/or COPD in NOVELTY/ C. Janson, Uppsala, Sweden P714 Blocking Either the IL-33 or IL-4R a Pathway Attenuates Inflammatory Mediators of Airway Disease/ S. Asrat, Tarrytown, NY P715 The Role of TRPAl Channel in Cold Air-Induced Aggravation of Airway Inflammation/ Y. Dotake, Kagoshima-shi, Japan

CLINICAL THEMATIC POSTER SESSION

B32

WHEEZES, HIVES, AND THERAPIES GONE AWRY

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area G, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P726 Beginning With An Ace Of Spades And Ending With A Clot Of Hearts- Hypereosinophilic Syndrome With Left Ventricular Thrombus/ B. Amir-Kabirian, Charleston, WV P727 When Addiction Medicine and Pulmonary Medicine Intersect: Two Cases of Eosinophilic Pneumonia Secondary to Intramuscular Naltrexone/ A.G. Ryden, Salt Lake City, UT P728 A Case of Successful Use of Benralizumab in a Patient With Chronic Eosinophilic Pneumonia (CEP)/ A. Jain, Valhalla, NY

ATS 2023 • Washington, DC